SUNRISE Aims to Create a Comprehensive, Engaging, and Sustainable Digital Health Promotion Program That Not Only Addresses Immediate Health Behaviours But Also Instils Lifelong Healthy Habits Among Adolescents. It is a Unique, Digitally Enhanced Program Combining Different Digital Solutions With New
Launched by BIOCRUCES BIZKAIA HEALTH RESEARCH INSTITUTE · Apr 9, 2025
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The SUNRISE trial is an exciting new project that aims to help young people develop healthy habits to prevent cancer. By using digital tools like educational games, social media campaigns, and health-related ads, this program will be integrated into schools across eight European countries, including Greece, Spain, and Italy. The goal is to make learning about health fun and engaging for students aged 10 to 19, particularly focusing on inclusivity for those from different backgrounds, including urban and rural areas and socially disadvantaged groups.
To participate in the trial, students must be at least 10 years old, have access to the internet through a device, and provide consent to join, along with permission from their parents if needed. While the trial is not yet recruiting participants, those who join can expect to engage in activities designed to make healthy living a lifelong habit. This program represents a significant step in promoting cancer prevention among adolescents, aiming to create lasting positive changes in their health behaviors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Minimum Age: Students must be at least 10 years old at the time of enrolment.
- • Devices and Internet Access: Students must have access to an electronic device with Internet connectivity.
- • Informed Consent: Students must provide their signed informed consent to participate in the study.
- • Parental Consent: Students, when necessary, must obtain and submit signed informed consent from a parent or legal guardian.
- Exclusion Criteria:
- • Age Restrictions: Students who are younger than 10 years or older than the established age range for participation.
- • Consent Issues: Students who have not signed the informed consent form or do not have signed informed consent from their parents or legal guardians.
- • Follow-up Limitations: Students who are unable to commit to the follow-up period of at least 18 months or are unlikely to complete the study.
About Biocruces Bizkaia Health Research Institute
Biocruces Bizkaia Health Research Institute is a leading research organization based in the Basque Country, Spain, dedicated to advancing health and medical knowledge through innovative clinical trials and research initiatives. With a strong emphasis on multidisciplinary collaboration, the institute focuses on translating scientific discoveries into tangible health solutions, fostering partnerships with academic institutions, healthcare providers, and industry stakeholders. Biocruces Bizkaia is committed to enhancing patient care and outcomes by conducting rigorous clinical research that adheres to the highest ethical and scientific standards. Its comprehensive expertise spans various medical fields, making it a pivotal player in the landscape of health research and innovation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nicosia, , Cyprus
Heraklion, , Greece
Roma, , Italy
Cluj Napoca, , Romania
Maribor, , Slovenia
Zürich, , Switzerland
Zürich, , Belgium
Valencia, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported